Article info

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

Authors

  1. Correspondence to Professor Geltrude Mingrone, Universita Cattolica del Sacro Cuore, 20123 Milano, Italy; geltrude.mingrone{at}unicatt.it
View Full Text

Citation

Mingrone G, van Baar AC, Devière J Investigators of the REVITA-2 Study, et al
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

Publication history

  • Received November 13, 2020
  • Revised December 26, 2020
  • Accepted January 30, 2021
  • First published February 17, 2021.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.